Marcia S. Brose, MD, PhD - A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes


Manage episode 282399843 series 103582
Player FM과 저희 커뮤니티의 PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Go online to to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in managing patients with thyroid cancer discusses the scientific background and rationale for molecular testing and targeted treatment of RET fusion/mutation–positive thyroid cancers, new data on novel targeted approaches, the importance of multidisciplinary collaboration, and how to effectively communicate with patients to promote shared decision-making and improve outcomes. Upon completion of this activity, participants should be better able to: Describe the heterogeneity of thyroid cancers and the rationale for integrating molecular testing into practice to inform treatment decisions, Discuss the evolving evidence on molecular testing for RET fusions/mutations in thyroid cancer and best practices for its use to guide therapy selection, Evaluate clinical trial data on novel, targeted therapies for patients with thyroid cancers that harbor genomic abnormalities, such as RET fusions/mutations, Implement collaborative strategies among endocrinologists, pathologists, and oncologists to ensure widespread genomic testing to identify appropriate patients for RET-targeted therapy in the context of clinical practice or clinical trials, Communicate effectively with patients with thyroid cancer to address their concerns and questions about their disease, treatment options, and prognosis and promote shared decision-making.

63 에피소드